A proteomics view of virulence factors of staphylococcus aureus

Genome Dynamics

Volumn 6, Issue , 2009, Pages 187-197

  Engelmann, S ^a   Hecker, M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSORY GENE REGULATOR; BACTERIAL PROTEIN; BINDING PROTEIN; CHEMOTAXIS INHIBITORY PROTEIN; COAGULASE; COLLAGEN BINDING PROTEIN; ELASTIN BINDING PROTEIN; EXFOLIATIN; FIBRINOGEN BINDING PROTEIN; FIBRONECTIN BINDING PROTEIN; HEMOLYSIN; IMMUNOGLOBULIN G BINDING PROTEIN; LEUKOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEASE; PROTEINASE; STAPHYLOCOCCAL ACCESSORY REGULATOR; STAPHYLOKINASE; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ISOLATE; COMMENSAL; EXTRACELLULAR SPACE; GEL; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMORAL IMMUNITY; LIQUID CHROMATOGRAPHY; NONHUMAN; OPERON; PATHOGENICITY; PATHOGENICITY ISLAND; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEOMICS; QUORUM SENSING; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSCRIPTOMICS; GENETICS; MICROBIOLOGY;

STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; PROTEOMICS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 77951084297     PISSN: 16609263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000235771     Document Type: Review

References (43)

1. Dinges MM, Orwin PM, Schlievert PM: Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
2. Foster TJ, Hook M: Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6: 484-488.
3. Foster TJ: Immune evasion by staphylococci. Nat Rev Microbiol 2005;3:948-958.
4. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
5. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, et al: Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 2002;70:4987-4996.
6. Lindsay JA, Holden MT: Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004;12: 378-385.
7. Novick RP: Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003;49: 93-105.
8. Witney AA, Marsden GL, Holden MT, Stabler RA, Husain SE, et al: Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol 2005;71:7504-7514.
9. von Eiff C, Becker K, Machka K, Stammer H, Peters G: Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11-16.
10. Lindsay JA, Moore CE, Day NP, Peacock SJ, Witney AA, et al: Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 2006;188:669-676.
11. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-759.
12. Jarraud S, Lyon GJ, Figueiredo AM, Gerard L, Vandenesch F, et al: Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 2000;182:6517-6522.
13. Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, et al: Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002;46:1492-1502.
14. Blevins JS, Beenken KE, Elasri MO, Hurlburt BK, Smeltzer MS: Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect Immun 2002;70:470-480.
15. Li S, Arvidson S, Mollby R: Variation in the agrdependent expression of alpha-toxin and protein A among clinical isolates of Staphylococcus aureus from patients with septicaemia. FEMS Microbiol Lett 1997;152:155-161.
16. Karlsson A, Arvidson S: Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect Immun 2002;70:4239-4246.
17. Sibbald MJ, Ziebandt AK, Engelmann S, Hecker M, de Jong A, et al: Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol Mol Biol Rev 2006;70:755-788.
18. Ziebandt AK, Weber H, Rudolph J, Schmid R, Her D, et al: Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 2001;1:480-493.
19. Bernardo K, Fleer S, Pakulat N, Krut O, Hunger F, Krke M: Identification of Staphylococcus aureus exotoxins by combined sodium dodecyl sulfate gel electrophoresis and matrix-assisted laser desorption/ ionization-time of flight mass spectrometry. Proteomics 2002;2:740-746.
20. Kawano Y, Ito Y, Yamakawa Y, Yamashino T, Horii T, et al: Rapid isolation and identification of staphylococcal exoproteins by reverse phase capillary high performance liquid chromatography-electrospray ionization mass spectrometry. FEMS Microbiol Lett 2000;189:103-108.
21. Kawano Y, Kawagishi M, Nakano M, Mase K, Yamashino T, et al: Proteolytic cleavage of staphylococcal exoproteins analyzed by two-dimensional gel electrophoresis. Microbiol Immunol 2001;45:285-290.
22. Rogasch K, Rmling V, PanFarrJ, Her D, Weinberg C, et al: Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J Bacteriol 2006;188:7742-7758.
23. Ziebandt AK, Becher D, Ohlsen K, Hacker J, Hecker M, Engelmann S: The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 2004;4: 3034-3047.
24. Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, et al: Global analysis of community- associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol 2007;9: 1172-1190.
25. Moisan H, Brouillette E, Jacob CL, Langlois-Begin P, Michaud S, Malouin F: Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 2006;188:64-76.
26. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, et al: Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 2005; 187:2426-2438.
27. Novick RP: Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003;48:1429-1449.
28. Morfeldt E, Tegmark K, Arvidson S: Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol Microbiol 1996;21:1227-1237.
29. Chien Y, Manna AC, Cheung AL: SarA level is a determinant of agr activation in Staphylococcus aureus. Mol Microbiol 1998;30:991-1001.
30. Janzon L, Arvidson S: The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J 1990;9:1391-1399.
31. Morfeldt E, Taylor D, von Gabain A, Arvidson S: Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J 1995;14:4569-4577.
32. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S: Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 1993;12:3967-3975.
33. Bischoff M, Entenza JM, Giachino P: Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus. J Bacteriol 2001; 183:5171-5179.
34. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ: SigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 2002;184: 5457-5467.
35. Goerke C, Campana S, Bayer MG, D?ing G, Botzenhart K, Wolz C: Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun 2000; 68:1304-1311.
36. Goerke C, Fluckiger U, Steinhuber A, Zimmerli W, Wolz C: Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol 2001;40:1439-1447.
37. Fournier B, Klier A, Rapoport G: The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol 2001;41:247-261.
38. Dubrac S, Boneca IG, Poupel O, Msadek T: New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J Bacteriol 2007;189: 8257-8269.
39. Holtfreter S, Roschack K, Eichler P, Eske K, Holtfreter B, et al: Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 2006;193:1275-1278.
40. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, et al: Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004;364:703-705.
41. Clarke SR, Brummell KJ, Horsburgh MJ, McDowell PW, Mohamad SA, et al: Identification of in vivoexpressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 2006;193:1098-1108.
42. Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, et al: Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2002;2:580-590.
43. Wolff S, Hahne H, Hecker M, Becher D: Complementary analysis of the vegetative membrane proteome of the human pathogen Staphylococcus aureus. Mol Cell Proteomics 2008;7: 1460-1468.